Indoco Remedies Limited reported a net loss of Rs 3.64 crore for the quarter ended June 30, 2025 (Q1FY26), compared to a profit of Rs 1.82 crore in the corresponding quarter last year. This marks the second consecutive quarter of losses, as the company had posted a Rs 4.13 crore loss in Q4FY25.
Revenue from operations in Q1FY26 stood at Rs 42.91 crore, up marginally from Rs 42.43 crore reported in Q1FY25. Including other operating income of Rs 8.81 crore, total income for the quarter reached Rs 43.79 crore. With additional other income of Rs 1.63 crore, total income was Rs 43.95 crore, a slight increase from Rs 43.25 crore YoY.
Despite the revenue uptick, expenses surged significantly to Rs 47.62 crore in Q1FY26, up from Rs 42.56 crore in the same quarter last year. Key cost drivers included higher raw material costs (Rs 10.55 crore), employee expenses (Rs 10.7 crore), and other operating expenses (Rs 15.67 crore). Finance costs also increased to Rs 2.61 crore from Rs 1.43 crore YoY.
The company reported a loss before tax of Rs 3.66 crore, with no exceptional items during the quarter. Tax expenses for the quarter were negligible, resulting in a final net loss of Rs 3.64 crore.
The results highlight the pressure Indoco Remedies is facing despite stable revenues, with rising costs weighing heavily on profitability.
